For the second quarter of 2024, the Company expects to report revenue of $17.6 million to $17.8 million, GAAP diluted earnings per share of $0.33 to $0.36, and non-GAAP diluted earnings per share of $0.36 to $0.39.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRMD:
- IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
- iRadimed files $75M common stock offering
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference